Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines

Insulin degludec/insulin aspart (IDegAsp) is a fixed‐ratio co‐formulation of insulin degludec, which provides long‐lasting basal insulin coverage, and insulin aspart, which targets postprandial glycaemia. This review provides expert opinion on the practical clinical use of IDegAsp, including: dose t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Roopa, Chen, Roger, Hirose, Takahisa, John, Mathew, Kok, Adri, Lehmann, Roger, Unnikrishnan, Ambika Gopalakrishnan, Yavuz, Dilek Gogas, Fulcher, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689716/
https://www.ncbi.nlm.nih.gov/pubmed/32618405
http://dx.doi.org/10.1111/dom.14128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689716/
https://www.ncbi.nlm.nih.gov/pubmed/32618405
http://dx.doi.org/10.1111/dom.14128

Ejemplares similares